Zai Lab Limited (ZLAB)

AI Score

Unlock

33.59

1.06 (3.26%)

At close: Apr 23, 2025, 3:59 PM

33.16

-1.28%

Pre-market: Apr 24, 2025, 08:24 AM EDT

Dividends

No dividend history available for Zai Lab Limited.

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield

Dividend Rankings

ZLAB News

2 days ago · Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors - businesswire.com
1 week ago · All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy - zacks.com
1 week ago · Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - zacks.com
4 weeks ago · Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - businesswire.com
1 month ago · Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth - seekingalpha.com
1 month ago · Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks - seekingalpha.com
1 month ago · Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer - businesswire.com
1 month ago · Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - zacks.com
1 month ago · Zai Lab Announces Participation in Investor Conferences in March 2025 - businesswire.com
1 month ago · Zai Lab Limited (ZLAB) Q4 2024 Earnings Call Transcript - seekingalpha.com